Investigates the antimicrobial activity of Schiff base complexes in various bacterial strains, suggesting potential applications.
In this study, transition complexes of Fe(III), Zn(II), La(III), Ce(III), and Pr(III) with a Schiff base ligand (L), which is derived from 3-hydroxybenzaldehyde and sulfamethoxazole, as the primary ligand, and L-Leucinate as a secondary ligand. The bonding mode of the Schiff base has been confirmed through a range of techniques, including infrared, UV-visible (UV-Vis), carbon and proton nuclear magnetic resonance spectroscopy, mass spectrometry, and elemental analysis. All complexes were characterized by elemental analysis, conductivity measurements, and spectroscopic techniques, including UV-Vis and Fourier transform infrared spectroscopy. A thorough discussion is provided on the structural and bonding features of the mixed ligand complexes formed from the Schiff base (L) and L-Leucine with ions [Fe (III), Zn(II), La(III), Ce(III), and Pr(III)], based on results from various research studies. Additionally, the antimicrobial activity of these complexes was evaluated against two Gram-positive and two Gram-negative bacterial strains. Furthermore, antifungal activity against Candida was evaluated, with tetracycline as the reference.
No takes yet. Share an insight, caveat, or question.
Abdulsalam et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: